home email sign-up search
HealthCast Calendar
Daily Reports Health Poll Search
Issue Spotlight
Daily Reports
Daily Health Policy Report
  Calendar
  Recent Reports
  Search these Archives
Daily HIV/AIDS Report
Weekly Health Disparities Report
First Edition
Email Alert Sign-Up
Editorial Policies
Search All Daily Reports Archives
 

Site Search

 



Kaiser Daily Health Policy Report


Thursday, March 25, 2004

Medicare

   Medicare Chief Actuary Foster Says He Informed White House Officials in June That Medicare Legislation Would Cost More Than Lawmakers Expected

Administration News

   Washington Post Looks at NIH Salaries, Conflict of Interest Policy

Capitol Hill Watch

   House Approves Legislation That Would Compensate Living Organ Donors for Expenses Related to Operations

Health Care Marketplace

   Tenet To Pay $30.7M To Settle Charges of Medicare Overbilling, Paying Physicians for Referrals To Tenet-Owned Hospitals

Prescription Drugs

   Caremark Rx Officials Announce Merger With Advance PCS Is Complete

   Reimported Prescription Drugs From Canada Are Safe, Report Prepared for New Hampshire Governor Says

   Generic Drug Companies File Lawsuit Against 'Authorized Generics'

Coverage & Access

   'Lou Dobbs Tonight' Examines Insurers' Marketing Tactics to the Uninsured

   Wall Street Journal Examines Employers' Proposal To Rate Doctors' and Hospitals' Quality and Cost of Care

State Watch

   Florida House Committee Passes Discounts For Uninsured Patients

   New Jersey To Provide Elderly Medicaid Beneficiaries With Alternatives to Nursing Home Care

New Releases

   The Latest Reports in Health Policy

Opinion

   Kaiser Daily Health Policy Report Features Editorial Response to Report From Medicare Trustees




Medicare
 

    Medicare Chief Actuary Foster Says He Informed White House Officials in June That Medicare Legislation Would Cost More Than Lawmakers Expected
    [Mar 25, 2004]

      During House Ways and Means Committee hearing Wednesday, CMS chief actuary Richard Foster said that as early as June, he shared with Doug Badger, President Bush's health policy adviser, and James Capretta, associate director of the Office of Management and Budget, his analysis that the Medicare legislation would exceed its target spending goal, the New York Times reports. According to the New York Times, Foster's analysis showed that the legislation "would cost 25% to 50% more than the Bush administration's public estimates" (Pear, New York Times, 3/25). According to OMB estimates released after Congress passed the legislation, the Medicare law will cost $534 billion over the next 10 years, $134 billion more than estimated by the Congressional Budget Office. Foster has said that the higher cost projection was known before the final House and Senate votes on the legislation in November but that former CMS Administrator Tom Scully told him, "We can't let that get out" (Kaiser Daily Health Policy Report, 3/23). He said that his office's official estimate for the enacted legislation was not complete until Dec. 23, but that "top administration officials had known for several months of his higher cost estimates," the Los Angeles Times reports (Kemper, Los Angeles Times, 3/25). Foster said, "The range of our estimates was $500 billion to $600 billion all the way through the process" (New York Times, 3/25). In an e-mail to colleagues at CMS, Foster indicated he believed he might lose his job if he revealed his cost estimates for the Medicare legislation. Scully has said that he did not threaten to fire Foster if the higher estimates were released. Scully also said that he "curbed Foster on only one specific request" made by Democrats at the time of the first House vote on the Medicare bill. Scully said, "[Democrats] were trying to be politically cute" and get Foster to give an estimate on the bill "and put something out publicly so they [could] walk out on the House floor and cause a political crisis, which is bogus." Last week, HHS Secretary Tommy Thompson and 18 Senate Democrats requested that the department's Office of Inspector General and the General Accounting Office look into the issue (Kaiser Daily Health Policy Report, 3/23).

Administration's Knowledge
Foster told the committee that Scully had said he was "acting under direct White House orders" when he instructed Foster to withhold some internal cost estimates. Foster said he believed that the order came from Badger (Schuler/Carey, CQ Today, 3/24). Foster said that he was not sure if Thompson was aware of the higher estimates and could not recall if Badger or another administration official directly ordered him not to answer questions concerning his analysis (Los Angeles Times, 3/25). White House spokesperson Trent Duffy said that Badger does not remember telling anyone to withhold information from Congress. Foster told the committee on Wednesday that he would not disclose his "evidence" of the White House's involvement until he provided the details to the HHS OIG, according to the New York Times (New York Times, 3/25).

Legality of Scully's Orders
Foster told the committee that he "failed to convince Scully that congressional requests for information should be granted in the best interests of the public," the Philadelphia Inquirer reports. He added that he considered Scully's order to withhold information "inappropriate and, in fact, unethical" (Pugh, Philadelphia Inquirer, 3/25). However, Foster said that after contacting an HHS lawyer, he "ended up convinced the administrator had the legal right" to withhold the estimates from Congress (Goldstein, Washington Post, 3/25). According to the New York Times, Foster identified the lawyer as Leslie Norwalk, acting deputy administrator at CMS (New York Times, 3/25). Foster said that the lawyer explained to him that because he is an employee of the executive branch, he did not have to give information to the legislative branch. He said that while he found the "new policy on communication with Congress ... unethical," he also did not believe that the administration had broken any laws, Roll Call reports (Pierce, Roll Call, 3/25). Foster said that he discussed with Scully a report accompanying a 1997 law that says it is "imperative for the actuary to provide Congress with impartial cost estimates for legislative proposals," according to the New York Times. However, he said that Scully told him that report "meant nothing" because it was not in the law itself (New York Times, 3/25). Foster said, "I could ignore the order. I knew I would be fired" (Rodgers, Wall Street Journal, 3/25). He said while he had considered resigning "in protest," his staff convinced him to keep his position "to fight to preserve his office's independence," the Post reports (Washington Post, 3/25). He added, "I thought it would be better to work within the system" (Zaneski, Baltimore Sun, 3/25).

Democratic, Republican Response
Democrats "tried to use the hearing to illustrate what they called a cover-up that raised questions about the Bush administration's credibility," the Los Angeles Times reports (Los Angeles Times, 3/25). Rep. Sander Levin (D-Mich.) said, "There was a cover-up of some basic information," adding, "We had the right to know. They had the right to tell us what they knew and what they did not" (CQ Today, 3/24). Rep. John Tanner (D-Tenn.) said, "Every Republican and Democrat on this committee ought to be outraged at the willful, deliberate, sinister withholding of information" (New York Times, 3/25). Rep. Charles Rangel (D-N.Y.) said that the issue "shows the intimidation and how far the majority party was prepared to go to keep Congress in the dark" (USA Today, 3/25). Rangel added, "[Republicans] would not have had the votes to pass this if the cost of the bill was known" (Heil, CongressDaily, 3/25). According to the Los Angeles Times, Republicans at the hearing attempted to "undercut the validity of Foster's claims," saying that Congress is "legally bound to use" CBO's estimates (Los Angeles Times, 3/25). Rep. Wally Herger (R-Calif.) said to Foster, "You mentioned earlier that you were following the law," to which Foster answered, "Yes" (Roll Call, 3/25). Rep. Nancy Johnson (R-Conn.) said, "The law allows Mr. Scully to control the flow of information. While you might not like it, that's the law" (USA Today, 3/25). According to the Los Angeles Times, House Ways and Means Committee Chair Bill Thomas (R-Calif.) "did not defend Scully's stifling of Foster," but he "encouraged Foster to confirm that [Thomas] had offered the actuary his moral support when the Scully-Foster dispute first erupted in June" (Los Angeles Times, 3/25). Thomas said, "I supported you then. I support you now" (New York Times, 3/25).

Estimate Discrepancies
During the hearing, CBO Director Douglas Holtz-Eakin addressed his agency's and OMB's estimates for the Medicare legislation, noting that the offices made different assumptions about the legislation. However, he said, "It is my judgment that $395 billion was and remains the single best estimate of the cost of this legislation" (USA Today, 3/25). Foster's estimates that were given to Congress last week show that $32 billion of the difference between the OMB and CBO estimates is related to increased payments to private plans participating in Medicare. Accounting for another $32 billion of the difference, CBO assumed that 87% of eligible seniors would participate in the prescription drug benefit, while OMB assumed that 94% of elderly would participate, according to the documents (Kaiser Daily Health Policy Report, 3/23). Foster said during the hearing, "The fact that we disagree somewhat ... is because the future is uncertain" (Baltimore Sun, 3/25).

Senators Request DOJ Probe
Sens. Hillary Rodham Clinton (D-N.Y.), Edward Kennedy (D-Mass.), Frank Lautenberg (D-N.J.) and Debbie Stabenow (D-Mich.) on Wednesday sent Attorney General John Ashcroft a letter requesting a Department of Justice investigation into whether Bush administration officials violated two federal criminal laws prohibiting the withholding from Congress certain information. The letter says that current laws can impose fines or five years of imprisonment for "whoever corruptly, or by threats of force, or by any threatening letter or communications influences, obstructs or impedes ... the due and proper inquiry under which any inquiry or investigation is being had by either House or any committee of either House or any joint committee of Congress" (Roll Call, 3/25). The senators also said that Foster's allegation possibly constitutes "obstruction of proceedings before departments, agencies and committees." DOJ officials on Wednesday night said that the request was being reviewed (Philadelphia Inquirer, 3/25). A Senate Democratic aide said it is likely that Ashcroft would open a criminal inquiry in the next few days, Roll Call reports (Roll Call, 3/25).

Broadcast Coverage
A HealthCast of the Ways and Means hearing is available online at kaisernetwork.org.

A HealthCast of an American Enterprise Institute discussion -- "Has the Drug Benefit Changes Medicare's Long-Term Outlook?" -- with Foster and others will be available online after 5 p.m. ET Thursday at kaisernetwork.org.

NBC's "Nightly News" Wednesday reported on Foster's testimony. The segment includes comments from Cybele Bjorklund, Democratic staff director for the House Ways and Means Subcommittee on Health; Foster; and Rep. Kenny Hulshof (R-Mo.) (Reid, "Nightly News," NBC, 3/24). The complete segment is available online in Windows Media.

NPR's "Morning Edition" Thursday included an interview with Marilyn Moon, health program director of the American Institutes for Research, about the Medicare estimates (Montagne, "Morning Edition," NPR, 3/25). The complete segment is available online in RealPlayer.

Email this story to a friend. Link to this story.
Print this story. Save this story in my saved links.

Administration News
 

    Washington Post Looks at NIH Salaries, Conflict of Interest Policy
    [Mar 25, 2004]

      The Washington Post on Thursday examined the salaries of the director of NIH and the heads of 27 agency centers amid questions about whether NIH should allow employees to receive "far more than would be possible under the General Schedule payroll system -- and at the same time disclose less than others about outside income and possible conflicts of interest" (Weiss, Washington Post, 3/25). In December, the Los Angeles Times found evidence of hundreds of consulting payments -- often hidden from the public -- to a number of NIH officials. In January, NIH Director Elias Zerhouni told the Senate Appropriations Subcommittee on Labor, Health and Human Services and Education that a new NIH committee chaired by two scientists from the public and private sectors would investigate allegations of conflicts of interest among NIH employees who received consulting payments and stock options from pharmaceutical companies. At a hearing held by the committee earlier this month, attorneys from the Office of Government Ethics announced new disclosure requirements, under which many director-level NIH scientists have to publicly disclose income received from outside sources. The disclosure requirements, effective as of Feb. 6, affect 66 senior NIH officials. Edgar Swindell, HHS associate general counsel, also announced earlier this month that the HHS Office of Inspector General has begun an examination of conflict-of-interest policies at NIH (Kaiser Daily Health Policy Report, 3/2).

Average Salaries
According to information obtained by the Post through the Freedom of Information Act and NIH sources, annual salaries for the NIH director and center heads range from $142,500 to $293,750 -- about the range of salaries for departmental undersecretaries, members of Congress, Supreme Court justices and the vice president. However, compared with private-sector professors, laboratory heads and department chairs with medical degrees in the Northeast, NIH officials "barely earn average regional salaries for their field," according to the Post. Private-sector researchers in the basic sciences have average salaries of $194,000, and those in the clinical sciences have average salaries of $253,000; NIH officials have average salaries of $198,000, the Post reports. NIH spokesperson John Burklow said, "NIH needs to remain reasonably competitive to continue to attract and retain the best and the brightest" to allow the agency to "lead our nation's fight against the most threatening diseases, such as AIDS, SARS, cancer and heart disease." He added, "For the opportunity to lead this fight, NIH directors accept much lower compensation compared to their counterparts in academia and the private sector" (Washington Post, 3/25).

Email this story to a friend. Link to this story.
Print this story. Save this story in my saved links.

Capitol Hill Watch
 

    House Approves Legislation That Would Compensate Living Organ Donors for Expenses Related to Operations
    [Mar 25, 2004]

      The House on Wednesday voted 414-2 to approve a bill (HR 3926) that would reimburse organ donors for travel and other nonmedical expenses involved in transplant surgery, the AP/Houston Chronicle reports. Beginning Oct. 1, the bill would allow HHS to spend $5 million a year to reimburse qualified donors and provide another $15 million for grants to states, public awareness campaigns and studies on improving recovery and donation rates (Kumar, AP/Houston Chronicle, 3/25). According to CQ Today, states, transplant centers, qualified organ procurement organizations and "other qualified organizations" would be eligible for the grants (CQ Today 3/24). The bill also would fund new programs to coordinate organ donations at hospitals and procurement agencies, CongressDaily reports (CongressDaily, 3/25). The bill now goes to the Senate, which in November passed a similar measure (S 573), for consideration (CQ Today 3/24).

Email this story to a friend. Link to this story.
Print this story. Save this story in my saved links.

Health Care Marketplace
 

    Tenet To Pay $30.7M To Settle Charges of Medicare Overbilling, Paying Physicians for Referrals To Tenet-Owned Hospitals
    [Mar 25, 2004]

      California-based Tenet Healthcare has agreed to pay $30.7 million to settle two federal inquiries into improper financial arrangements with doctors and "Medicare patient discharges and transfers," the Los Angeles Times reports. In one case, Tenet agreed to pay $22.5 million to resolve a lawsuit in which the Justice Department joined a whistleblower in alleging that North Ridge Medical Center in Fort Lauderdale, Fla., "improperly bill[ed] Medicare for patients referred by doctors who had financial relationships with the hospital," according to the Times. The suit, originally filed by former Tenet employee Sal Barbera, alleged that beginning in 1993, North Ridge violated a federal law prohibiting physicians from referring Medicare beneficiaries to facilities with which doctors have a financial relationship. The suit involved doctor contracts made between 1993 and 1995. Barbera will receive about $5 million from the settlement, which federal officials said is the "largest ever over such claims at a single hospital," the Times reports. Tenet admitted no wrongdoing in the settlement (Girion, Los Angeles Times, 3/25). The second case, which Tenet settled for $8.2 million, pertained to allegations that the company's hospitals overbilled Medicare by listing patients who had been transferred to another hospital as "discharged" instead of "transferred" to collect higher reimbursements (Appleby, USA Today, 3/25). Peter Urbanowitz, general counsel for Tenet, said the settlement of the two cases is "an important step forward as Tenet works to rebuild its business and reputation." The company still faces "myriad government investigations and private lawsuits related to a variety of business practices and to alleged unnecessary heart surgeries performed by doctors" at a California hospital, according to the Times. Tenet executives last week reassured investors that the company has enough cash to resolve all of the lawsuits (Los Angeles Times, 3/25).

Headquarters Move
In other Tenet news, company President and CEO Trevor Fetter last week in a memo to employees said that Tenet may move its headquarters from Santa Barbara, Calif. According to the Journal, the move is part of an effort to "placate shareholders who have criticized the hospital chain for locating its corporate offices in a coastal resort town far from major airports." In the memo, Fetter said that "it's clear to everyone that the Santa Barbara headquarters location was originally created for the personal convenience of the top executives of this company" and that he is making it a priority to do away with "a tradition of self indulgence at the top." A decision on where the company will locate its new headquarters is expected within 90 days. The Journal reports that Dallas is "the most logical place for relocation" in part because Tenet already maintains a large operation there. Tenet said that if it decides to close the Santa Barbara office, the closure would not take place before mid-2005 (Rundle, Wall Street Journal, 3/25).

Email this story to a friend. Link to this story.
Print this story. Save this story in my saved links.

Prescription Drugs
 

    Caremark Rx Officials Announce Merger With Advance PCS Is Complete
    [Mar 25, 2004]

      Officials for Tennessee-based pharmacy benefit manager Caremark Rx on Wednesday announced that the company has completed a more than $6 billion merger with Texas-based PBM Advance PCS, the Tennessean reports. Shareholders for both companies earlier this week approved the merger, which will create the second-largest PBM in the nation (Russell, Tennessean, 3/25). Caremark in September 2003 announced plans to purchase AdvancePCS for $5.6 billion in stock and cash. The merged company will process about 600 million prescriptions per year and will have estimated annual revenue of $23 billion. The merger will provide Caremark with a 20% market share as measured by prescriptions processed, compared with a 22% market share for Medco Health Solutions, the largest PBM in the nation. The merger raised concerns about the potential effect on competition in the PBM market, as well as the $5.6 billion price, which some analysts considered overvalued. However, the Federal Trade Commission approved the merger after an investigation into the potential effects on competition in the PBM market. According to FTC, PBMs will face adequate competition to make the market viable, and competition from other PBMs, pharmacies and health insurers "should suffice to prevent this acquisition from giving rise to a potentially anticompetitive price increase" (Kaiser Daily Health Policy Report, 2/12).

Email this story to a friend. Link to this story.
Print this story. Save this story in my saved links.

 

    Reimported Prescription Drugs From Canada Are Safe, Report Prepared for New Hampshire Governor Says
    [Mar 25, 2004]

      New Hampshire officials have prepared a report for Gov. Craig Benson (R) that indicates U.S.-manufactured prescription drugs reimported from Canada are safe, state Department of Health and Human Services Commissioner John Stephen said on Wednesday, the Manchester Union Leader reports (Hayward, Manchester Union Leader, 3/25). Benson has sought approval from HHS Secretary Tommy Thompson to establish a state reimportation program for Medicaid beneficiaries and prison inmates (Kaiser Daily Health Policy Report, 2/23). Under the program, New Hampshire would reimport from Canada prescription drugs manufactured in the United States and shipped in their original packages. The program also would require both a U.S. and a Canadian physician to approve prescriptions. For the report, state officials ordered reimported prescription drugs from Canada and purchased the same medications in New Hampshire. The state crime laboratory performed a blind analysis on the medications and found no difference between the two samples, Stephen said. He declined to discuss specific details but said that the report "clearly shows there is quality of service and the practices (in Canada) are safe and effective, and health and safety will in no way be compromised." Benson visited Washington, D.C., on Wednesday to meet with Thompson to discuss the proposed state reimportation program. The governor also has proposed that New Hampshire join a purchasing pool with Michigan and Vermont to negotiate lower prescription drug prices for state programs. In addition, Benson has announced plans to establish a Web site that will provide state residents with access to Canadian pharmacies certified as safe. The New Hampshire Medicaid program spends about $140 million per year on prescription drugs, and the cost of the medications has increased by double-digit percentages in each of the past three years, according to Stephen (Manchester Union Leader, 3/25).

Email this story to a friend. Link to this story.
Print this story. Save this story in my saved links.

 

    Generic Drug Companies File Lawsuit Against 'Authorized Generics'
    [Mar 25, 2004]

      Generic drug company Mylan Laboratories on Wednesday filed a lawsuit in U.S. District Court in San Francisco against "authorized generics," a new tactic used by some brand-name drug companies to "undercut the profits of some of their generic rivals," the Wall Street Journal reports. An authorized generic results when a brand-name manufacturer licenses its drug to a generic drug company it selects, thus "undermin[ing] a rival generic drug company that plans to copy the drug," the Journal reports. Sometimes, the authorized generic is made by the brand-name company and distributed by the generic company. Such deals often involve drugs that are about to lose patent protection because a generic company has challenged the patent in court. Under current law, the first generic drug to market has six months of market exclusivity. However, the authorized copies do not have to abide by the six-month waiting period and can "immediately cut into the rival generic maker's sales," the Journal reports. The lawsuit, filed against Procter & Gamble and Watson Pharmaceuticals, contends that their distribution of an authorized generic version of P&G's Macrobid, an antibiotic for urinary tract infections, violates federal law. The lawsuit also argues that P&G and Watson are deceiving consumers by selling the same product at two different prices. A spokesperson for P&G said that the lawsuit is "without merit," the Journal reports. The spokesperson added that the planned generic version of Macrobid would "result in more consumer choices." However, Heather Bresch, a spokesperson for Mylan, said, "We're committed to doing whatever we can to stop this practice." In addition to the lawsuit, Mylan last month petitioned FDA to amend its regulations to require authorized generics to abide by the six-month exclusivity period.

Practice Dividing Industry
The use of authorized generics is "dividing the generic drug industry," the Journal reports. Some companies, such as Watson and Par Pharmaceutical, contend that partnering with brand-name companies is a good strategy and allows consumers to benefit from the availability of two less-costly alternatives to a brand-name drug. However, generic drug industry "heavyweights" Mylan, Teva Pharmaceutical Industries and Barr Laboratories contend that authorized generics "threaten the profitability and long-term health of the industry," according to the Journal. In addition, opponents say that authorized generics mean that fewer generics will come to market in the long run. Last month, the Generic Pharmaceutical Association came out against the practice (Abboud, Wall Street Journal, 3/25).

Email this story to a friend. Link to this story.
Print this story. Save this story in my saved links.

Coverage & Access
 

    'Lou Dobbs Tonight' Examines Insurers' Marketing Tactics to the Uninsured
    [Mar 25, 2004]

      In the third segment of a series titled, "Middle Class Squeeze: Health Care in America," CNN's "Lou Dobbs Tonight" on Wednesday reported on health insurers that are "pitching individual coverage directly" to uninsured U.S. residents who are not "financially strapped." According to CNN, nearly 60% of 1.5 million recently uninsured U.S. residents have annual incomes of $75,000 or more. However, according to Aetna Senior Vice President for Consumer Markets William Roth, some uninsured lack information about how to buy individual health insurance coverage or have decided "that they would rather spend their money elsewhere." CNN reports that insurers are "scrambling" to "lure customers" in this market with more competitive rates and tailored individual coverage plans, such as catastrophic coverage only or specialized drug plans. Karen Ignagni, president of America's Health Insurance Plans, the newly merged AAHP/HIAA, said, "The common conclusion now is that one size doesn't fit all, that we need to have a solution with respect to the uninsured that really reflects the diversity of this population." The fourth segment of the series, which airs Thursday, will examine the reasons more young adults than other age groups are uninsured in the United States (Pilgrim, "Lou Dobbs Tonight," CNN, 3/24). A complete transcript of the third segment is available online.

Email this story to a friend. Link to this story.
Print this story. Save this story in my saved links.

 

    Wall Street Journal Examines Employers' Proposal To Rate Doctors' and Hospitals' Quality and Cost of Care
    [Mar 25, 2004]

      The Wall Street Journal on Thursday looked at several employers' plan to join together to develop a consumer guide ranking the quality and cost efficiency of doctors and hospitals. Sprint, J.C. Penney, BellSouth, Morgan Stanley and 24 other companies plan to use claims data from insurers and pharmacies to measure how doctors "stack up against" quality standards based on medical evidence, and the employers will publish the results in a guide similar to Consumer Reports or Zagat, according to project leader David Rahill of Mercer Human Resource Consulting. The ratings will be based on standards set by independent groups such as the National Committee for Quality Assurance, the Joint Commission on Accreditation of Healthcare Organizations and the National Quality Forum. The companies say the scorecards will help employees choose care based on quality and cost and will bring to light inconsistencies and error rates in care. Sharon Leight, manager of benefits at J.C. Penney, said, "We have an obligation to give our employees more information." However, some observers are concerned that such quality data would be oversimplified and would not take into account certain factors affecting outcome. Dr. Bruce Landon, a health policy researcher at Harvard Medical School, said, "The more quality measures the better, but we don't want the information to be misleading." He added, "Without the appropriate statistical models, ... people are going to be misclassified." (Landro, Wall Street Journal, 3/25). NPR's "Morning Edition" Thursday included an interview with Wall Street Journal reporter Laura Landro about the physician rating system (Montagne, "Morning Edition," NPR, 3/25). The complete segment is available online in RealPlayer.

Email this story to a friend. Link to this story.
Print this story. Save this story in my saved links.

State Watch
 

    Florida House Committee Passes Discounts For Uninsured Patients
    [Mar 25, 2004]

      The Florida House Health Care Committee on Tuesday voted 14-6 to approve a bill that would require hospitals to provide discounts to people who have no insurance coverage and whose annual incomes are up to 300% of the federal poverty level, the Miami Herald reports. Under the bill, sponsored by state Rep. Marcelo Llorente (R), hospitals would be allowed to charge patients only twice the rate that they charge for those covered by Medicare. The measure would require hospitals to create a policy for "self-pay patients" and inform them of the discounts for which they are qualified. The bill "is a response to increasing criticism by consumer groups" regarding the "inequitable rate system" for uninsured and insured patients, the Herald reports. According to the Herald, under the current system, uninsured patients receive bills that can equal "as much as five times what [hospitals] charge [insured] patients." Llorente said, "[I]t's very important for consumers who want to pay their debts to see a bill that's three or four times less than they've been given," adding, "It's an issue of compassion for persons that are uninsured." The state Senate has yet to consider similar legislation. According to the Herald, the state House bill has "changed significantly" since the Florida Hospital Association in January gave its support for such a measure. According to the Herald, the association is concerned that the changes to the rate policy could "have unintended consequences." Rich Rasmussen, FHA communications director, also said that because the bulk of uninsured patients treated in Florida hospitals are children and pregnant women, the hospitals are not clear on what guidelines to use to charge them under the new measure because neither group typically is covered by Medicare (Klas, Miami Herald, 3/24).

Email this story to a friend. Link to this story.
Print this story. Save this story in my saved links.

 

    New Jersey To Provide Elderly Medicaid Beneficiaries With Alternatives to Nursing Home Care
    [Mar 25, 2004]

      New Jersey Gov. James McGreevey (D) on Tuesday signed an executive order directing the state Department of Health and Senior Services to implement a system that would help elderly beneficiaries of Medicaid obtain care in community settings rather than in nursing homes, the Newark Star-Ledger reports. Medicaid beneficiaries already qualify for nursing home care, but they must obtain special permission to receive in-home or assisted living care, a process that can take months. Nursing home care costs about $120 per day, compared with about $60 per day for assisted living centers (Hester, Newark Star-Ledger, 3/24). McGreevey hopes to reduce the paperwork needed for Medicaid beneficiaries to receive in-home or assisted living care and to develop plans to improve and create alternative long-term care programs for beneficiaries (Albin, New York Times, 3/24). The goal is to move at least 20% of the 29,000 elderly Medicaid beneficiaries who are in nursing homes to their own houses or to assisted living centers. The move would allow the state to enroll more seniors in Medicaid. The executive order also directs HSS to launch two new Medicaid initiatives this year: one would allocate funds to 14 county offices on aging for in-home services and one would provide seven counties with help to provide respite care programs for in-home caregivers. The programs would cost $7 million. All New Jersey counties will be able to compete to participate in the programs. The order also directs HSS to expand from 70 to 170 participants in a program that allows seniors to live with "a caring family or individual willing to look after them." The expansion will cost $1.5 million. McGreevey said, "The whole goal is to look at a number of different options. We want to keep seniors active and engaged in the community. It is a long-overdue change and an argument for common sense." Marilyn Askin, president of the New Jersey chapter of AARP, which originally proposed McGreevey's plan, said, "We are very happy to see the governor's commitment to fast-track the process of obtaining Medicaid eligibility for home-care options for those who qualify" (Newark Star-Ledger, 3/24).

Email this story to a friend. Link to this story.
Print this story. Save this story in my saved links.

New Releases
 

    The Latest Reports in Health Policy
    [Mar 25, 2004]

     

Email this story to a friend. Link to this story.
Print this story. Save this story in my saved links.

Opinion
 

    Kaiser Daily Health Policy Report Features Editorial Response to Report From Medicare Trustees
    [Mar 25, 2004]

      Several newspapers recently published editorials in response to the 2004 annual report that Medicare trustees released on Tuesday. The report found that the Medicare hospital trust fund will become insolvent by 2019, seven years earlier than the estimate last year. The report, which Medicare trustees based on analysis from the office of chief CMS actuary Richard Foster, attributed the new estimate to increased health care costs, lower-than-expected revenue from payroll taxes and revisions to the program enacted in the new Medicare law (Kaiser Daily Health Policy Report, 3/24). Summaries of the editorials appear below.

  • Akron Beacon Journal: The report is "disturbing," but "fluctuations in the annual projections should temper alarm over the latest estimates," according to a Beacon Journal editorial. In response, lawmakers should "examine the causes of the financial erosion and put together a plan to shore up the trust fund," rather than engage in "finger-pointing on Capitol Hill over which party is to blame," the editorial states (Akron Beacon Journal, 3/25).

  • Boston Globe: The report indicates that "it was irresponsible of Congress to put new stresses" on the Medicare program by "increasing payments to rural hospitals without raising taxes to pay for them" under the Medicare law, a Globe editorial states. The report "should prompt an honest debate on how to raise the extra revenue to pay for Medicare Parts A and B and a limited drug benefit in the short term" and should "encourage discussion about the best way to offer federally guaranteed health insurance to younger Americans," the editorial states (Boston Globe, 3/25).

  • Detroit Free Press: The report "looks scary," but "it should not invoke fear or dread ... as much as it should provoke a renewed focus on what services this nation really wants to provide and how it will pay for them," according to a Free Press editorial. The editorial continues, "It is a mistake to view Medicare as a stand-alone program that can only be saved by slashing it," adding that "Americans need to weigh the value of protecting their elders' health in relation to tax cuts as well as to maintaining other government services" (Detroit Free Press, 3/25).

  • Long Island Newsday: "Republicans and Democrats are already concocting ways to blame each other" for problems with the finances of Medicare, but "the growing problem was entirely predictable, and it must be addressed seriously, not just to make debating points," according to a Newsday editorial. The editorial adds that "finding ways to more effectively manage the growth in the cost of medical care in general is the best remedy -- if an elusive one -- not only for Medicare users but for everyone" (Long Island Newsday, 3/25).

  • Los Angeles Times: The new Medicare prescription drug benefit will take effect in 2006, and "Congress needs to get the price of the benefit down ... before it goes into effect," a Times editorial states. According to the editorial, Congress should repeal the provision in the Medicare law under which the program cannot negotiate discounts on prescription drugs directly with pharmaceutical companies to help address the issue. The editorial adds that the legalization of prescription drug reimportation "is another measure that Congress should consider" (Los Angeles Times, 3/25).

  • Milwaukee Journal Sentinel: Congress can move to "make the Medicare program more solvent ... by looking for more cost-efficient ways to provide health care for older Americans," such as proposals that would legalize prescription drug reimportation and would allow Medicare to negotiate discounts on medications directly with pharmaceutical companies, a Journal Sentinel editorial states. In addition, "there still is time for a genuine bipartisan study commission that just might provide answers to the difficult questions posed by Medicare's latest longevity report," the editorial states (Milwaukee Journal Sentinel, 3/24).

  • Raleigh News & Observer: Although the reports attributed the financial problems of Medicare in part to "diminished revenue," the "knottier problem is the rising cost of health care," a News & Observer editorial states. The "Bush administration's free-market solution -- health savings accounts for workers" -- will not provide U.S. residents "assurance of a decent level of care when they're old and need it the most," the editorial states (Raleigh News & Observer, 3/25).

  • Washington Post: The report has "quantified" the impact that the failure of lawmakers to pass adequate revisions to the Medicare program in the new law could have "for the American taxpayer," and "not even optimists doubt that Congress, by approving a drug benefit without deeper reform, wasted a golden opportunity," a Post editorial states. Both Republicans and Democrats have indicated that "no one is prepared to discuss Medicare costs truthfully," the editorial states, adding, "Real reform will require not just bipartisan cooperation but bipartisan honesty" (Washington Post, 3/25).

HealthCast
A HealthCast of an American Enterprise Institute discussion -- "Has the Drug Benefit Changes Medicare's Long-Term Outlook?" -- with Foster and others will be available online after 5 p.m. ET Thursday at kaisernetwork.org.

Email this story to a friend. Link to this story.
Print this story. Save this story in my saved links.


Looking for a Daily Report on a specific date? Click here for instructions on how to find it. ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... .....


About Us     Help